Back to search

Article

Studies in alkaptonuria reveal new roles beyond drug clearance for phase I and II biotransformations in tyrosine metabolism

2020-04-16

Abstract excerpt

<h4>Background and Purpose</h4> alkaptonuria (AKU) is an inherited disorder of tyrosine metabolism caused by lack of the enzyme homogentisate 1,2-dioxygenase (HGD). The primary biochemical consequence of HGD-deficiency is increased circulating homogentisic acid (HGA), which is central to AKU disease pathology. The aim of this study was to investigate the wider metabolic consequences of targeted Hgd disruption....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2da17de-aefb-5896-a152-a01f53cf970b
DOI
10.1101/2020.04.16.044347
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Studies in alkaptonuria reveal new roles beyond drug clearance for phase I and II biotransformations in tyrosine metabolismDOI 10.1101/2020.04.16.044347
Select a neighboring publication to make it the new centre.